Your browser doesn't support javascript.
loading
Development of data processing algorithm to calculate adherence for adults with cystic fibrosis using inhaled therapy - a multi-center observational study within the CFHealthHub learning health system.
Sandler, Robert D; Lai, Lana; Dawson, Sophie; Cameron, Sarah; Lynam, Aoife; Sperrin, Matthew; Hoo, Zhe Hui; Wildman, Martin J.
Afiliación
  • Sandler RD; Adult CF Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Lai L; Sheffield Centre for Health and Related Research, The University of Sheffield, Sheffield, UK.
  • Dawson S; Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK.
  • Cameron S; Wolfson Adult Cystic Fibrosis Centre, Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Lynam A; Adult CF Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
  • Sperrin M; Cystic Fibrosis Unit, Southampton University Hospitals NHS Trust, Southampton, UK.
  • Hoo ZH; Division of Informatics, Imaging and Data Sciences, University of Manchester, Manchester, UK.
  • Wildman MJ; Adult CF Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Expert Rev Pharmacoecon Outcomes Res ; 24(6): 759-771, 2024 Jul.
Article en En | MEDLINE | ID: mdl-38458615
ABSTRACT

OBJECTIVES:

To develop a robust algorithm to accurately calculate 'daily complete dose counts' for inhaled medicines, used in percent adherence calculations, from electronically-captured nebulizer data within the CFHealthHub Learning Health System.

METHODS:

A multi-center, cross-sectional study involved participants and clinicians reviewing real-world inhaled medicine usage records and triangulating them with objective nebulizer data to establish a consensus on 'daily complete dose counts.' An algorithm, which used only objective nebulizer data, was then developed using a derivation dataset and evaluated using internal validation dataset. The agreement and accuracy between the algorithm-derived and consensus-derived 'daily complete dose counts' was examined, with the consensus-derived count as the reference standard.

RESULTS:

Twelve people with CF participated. The algorithm derived a 'daily complete dose count' by screening out 'invalid' doses (those <60s in duration or run in cleaning mode), combining all doses starting within 120s of each other, and then screening out all doses with duration < 480s which were interrupted by power supply failure. The kappa co-efficient was 0.85 (0.71-0.91) in the derivation and 0.86 (0.77-0.94) in the validation dataset.

CONCLUSIONS:

The algorithm demonstrated strong agreement with the participant-clinician consensus, enhancing confidence in CFHealthHub data. Publishingdata processing methods can encourage trust in digital endpoints and serve as an exemplar for other projects.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Algoritmos / Nebulizadores y Vaporizadores / Fibrosis Quística / Cumplimiento de la Medicación Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Algoritmos / Nebulizadores y Vaporizadores / Fibrosis Quística / Cumplimiento de la Medicación Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Expert Rev Pharmacoecon Outcomes Res Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Reino Unido